The preterm birth and Prelabor Rupture of Membranes (PROM) testing market size was USD 1.69 Billion in 2022 and is expected to register a rapid revenue CAGR of 2.8% during the forecast period. Key Pointers The fetal fibronectin test is ...
The global cancer biopsy market was USD 29.88 Billion in 2022 and is expected to register a revenue CAGR of 17% during the forecast period. Introduction of non-invasive biopsy techniques, such as liquid biopsy, as a result of improvements i...
The global biosimulation market was USD 2.78 Billion in 2022 and is expected to register a revenue CAGR of 16% during the forecast period. Key Pointers The software segment accounted for largest revenue share in 2022. The ...
The global biosensors market size was USD 28 billion in 2022 and is expected to register a revenue CAGR of 8% during the forecast period. Market revenue growth is primarily driven by factors such as increasing prevalence of chronic diseases...
The sternal closure systems market size was USD 2.4 Billion in 2022 and is expected to register a rapid revenue CAGR of 5% during the forecast period. Key Pointers The plate and screw systems segment accounted for largest revenue share ...
The smart card healthcare market was USD 6.18 Billion in 2022 and is expected to register a rapid revenue CAGR of 8% during the forecast period. Key Pointers The hybrid smart cards segment is expected to register fastest revenue growth ...
The Point of Care Glucose Testing (POCGT) market was USD 3.22 Billion in 2022 and is expected to register a rapid revenue CAGR of 4% during the forecast period. Key Pointers The Accu Check Aviva Meter segment is expected to account for ...
The Remote Patient Monitoring (RPM) market size was USD 53.6 billion in 2022 and is expected to register a rapid revenue CAGR of 26.7% during the forecast period. Key Pointers The stationary devices market is expected to account for lar...
The global diabetes devices market was USD 28.7 billion in 2022 and is expected register a revenue CAGR of 5.7% during the forecast period. Key Pointers The BGM devices segment accounted for largest revenue share in 2022. The insulin p...
The global biopharmaceuticals contract manufacturing market was USD 13.85 Billion in 2022 and is expected to register a revenue CAGR of 9% during the forecast period. Key Pointers The mammalian segment is expected to account for l...